PortfoliosLab logoPortfoliosLab logo
ANRO vs. NGD
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

ANRO vs. NGD - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Alto Neuroscience, Inc (ANRO) and New Gold Inc. (NGD). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period


ANRO

1D
-5.45%
1M
9.24%
6M
74.87%
YTD
52.08%
1Y
787.54%
3Y*
5Y*
10Y*
ALL TIME*
8.68%

NGD

1D
1M
6M
YTD
1Y
3Y*
5Y*
10Y*
ALL TIME*
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$10.54M$15.51M$12.41M

ANRO vs. NGD - Yearly Performance Comparison


2026 (YTD)20252024
ANRO
Alto Neuroscience, Inc
52.08%320.80%-80.77%
NGD
New Gold Inc.
4.25%251.21%90.77%

Correlation

The correlation between ANRO and NGD is 0.15, which is low. Their historical price movements had little consistent relationship.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.15

Correlation (All Time)
Calculated using the full available price history since Feb 2, 2024

0.09

Fundamentals

EPS

ANRO:

-$2.43

NGD:

$1.61

Total Revenue (TTM)

ANRO:

$0.00

NGD:

$1.46B

Gross Profit (TTM)

ANRO:

-$421.00K

NGD:

$758.26M

EBITDA (TTM)

ANRO:

-$74.36M

NGD:

$1.19B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

ANRO vs. NGD — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

ANRO
ANRO Risk / Return Rank: 9999
Overall Rank
ANRO Sharpe Ratio Rank: 100100
Sharpe Ratio Rank
ANRO Sortino Ratio Rank: 9999
Sortino Ratio Rank
ANRO Omega Ratio Rank: 9898
Omega Ratio Rank
ANRO Calmar Ratio Rank: 100100
Calmar Ratio Rank
ANRO Martin Ratio Rank: 100100
Martin Ratio Rank

NGD

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

ANRO vs. NGD - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Alto Neuroscience, Inc (ANRO) and New Gold Inc. (NGD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


ANRONGDDifference
Sharpe ratioReturn per unit of total volatility

Sortino ratioReturn per unit of downside risk

Omega ratioGain probability vs. loss probability

1.67

Calmar ratioReturn relative to maximum drawdown

23.08

Martin ratioReturn relative to average drawdown

60.27

ANRO vs. NGD - Sharpe Ratio Comparison


Loading charts...

Drawdowns

ANRO vs. NGD - Drawdown Comparison


Loading charts...

Drawdown Indicators


ANRONGDDifference

Max Drawdown

Largest peak-to-trough decline

-91.82%

Max Drawdown (1Y)

Largest decline over 1 year

-34.20%

Current Drawdown

Current decline from peak

-5.45%

Average Drawdown

Average peak-to-trough decline

-51.13%

Ulcer Index

Depth and duration of drawdowns from previous peaks

13.07%

Volatility

ANRO vs. NGD - Volatility Comparison


Loading charts...

Volatility by Period


ANRONGDDifference

Volatility (1M)

Calculated over the trailing 1-month period

17.38%

Volatility (6M)

Calculated over the trailing 6-month period

54.83%

Volatility (1Y)

Calculated over the trailing 1-year period

128.32%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

113.58%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

113.58%

Dividends

ANRO vs. NGD - Dividend Comparison

Neither ANRO nor NGD has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

ANRO vs. NGD - Financials Comparison

This section allows you to compare key financial metrics between Alto Neuroscience, Inc and New Gold Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items

Frequently Asked Questions


ANRO and NGD have a correlation of 0.15, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Portfolio Optimizer

Find the right allocation for ANRO and NGD

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer